glp 1 tirzepatide mounjaro (Mounjaro) FDA approves tirzepatide, Eli Lilly's

These interwoven networks highlight the reciprocal relationship between obesity, endocrine dysfunction, and reproductive health, underscoring the necessity for focused therapies to alleviate these impacts

About 23% of singular thyroid nodules are actually the largest nodule within a greater number of smaller ones, a condition known as a multinodular goiter

Obesity is a major part of the problem, its complications including chronic kidney disease, hypertensive disease, stroke, and liver disease negatively impacting quality but also quantity of life as life expectancy decreases as body mass index (BMI) increases [3]

Battle of the bowl Another issue with GLP-1 drugs is that they can cause intense gastrointestinal struggles